Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Assessment of Cellular Proliferation in Oral Verrucous Carcinoma and Well-Differentiated Oral Squamous Cell Carcinoma Using Ki67: A Non-Reliable Factor for Differential Diagnosis?

  • Zargaran, Massoumeh (Dental Research Center, Dental School, Hamadan University of Medical Sciences) ;
  • Eshghyar, Nosratollah (Department of Oral and Maxillofacial Pathology, Dental School, Hamadan University of Medical Sciences) ;
  • Baghaei, Fahimeh (Department of Oral and Maxillofacial Pathology, Dental School, Hamadan University of Medical Sciences) ;
  • Moghimbeigi, Abbas (Department of Biostatistics and Epidemiology, School of Public Health, Hamadan University of Medical Sciences)
  • Published : 2012.11.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Non-invasive oral verrucous carcinoma (OVC) and invasive well-differentiated oral squamous cell carcinoma (OSCC) have similar histopathologic findings but different biological behavior. These two malignancies must be correctly differentiated by pathologists. The aim of this study was to determine immunohistochemical (IHC) expression of Ki67 in OVC and well-differentiated OSCC. Methods: Expression of Ki67 was evaluated by IHC in 15 cases of epithelial hyperplasia with no dysplasia (A group), 15 cases of OVC (B group), 12 cases of microinvasive OSCC(C group) and 15 cases of well-differentiated OSCC (D group). Results: There was a significant difference in Ki67 expression based on pattern distribution of immunostaining positive cells, with quantitative and semi-quantitative analyses, among the four groups ; also, between A group and each of the other three groups (P=0.0001). But there was no significant difference between B and C, C and D, and B and D groups (P>0.05). Conclusions: The three evaluation methods of Ki67 expression showed Ki67 (Mib-1) is not a good immunohistochemical marker to assess invasion status and differentiate OVC from well-differentiated OSCC; also, it cannot be used as a diagnostic tool to distinguish between variants of OSCC with similar grade.

Keywords

References

  1. Ackerman LV (1948). Verrucous carcinoma of the oral cavity. Surgery, 23, 670-8.
  2. Adegboyega PA, Boromound N, Freeman DH (2005). Diagnostic utility of cell cycle and apoptosis regulatory proteins in verrucous squamous carcinoma. Appl Immunohistochem. Mol Morphol, 13,171-7. https://doi.org/10.1097/01.pai.0000132190.39351.9b
  3. Angadi PV, Krishnapillai R (2007). Cyclin D1 expression in oral squamous cell carcinoma and verrucous carcinoma: correlation with histological differentiation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 103, 30-5.
  4. Boas DS, Takiya CM, Coelho-Sampaio TL, et al (2010). Immunohistochemical detection of Ki-67 is not associated with tumor-infiltrating macrophages and cyclooxygenase-2 in oral squamous cell carcinoma. J Oral Pathol Med, 39, 565-70. https://doi.org/10.1111/j.1600-0714.2010.00883.x
  5. Celikel C, Eren F, Gulluoglu B, Bekiroglu N, Turhal S (2007). Relation of neuroendocrine cells to transforming growth factor-alpha and epidermal growth factor receptor expression in gastric adenocarcinomas: prognostic implications. Pathol Oncol Res, 13, 215-26. https://doi.org/10.1007/BF02893502
  6. Choi HR, Tucker SA, Huang Z, et al (2003).Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.Int J Oncol, 22, 409-14.
  7. de Moraes RV, Oliveira DT, Landman G, et al (2008). E-cadherin abnormalities resulting from CPG methylation promoter in metastatic and nonmetastatic oral cancer. Head Neck, 30, 85-92. https://doi.org/10.1002/hed.20666
  8. Drachenberg CB, Blanchaert R, Ioffe OB, Ord RA, Papadimitriou JC (1997). Comparative study of invasive squamous cell carcinoma and verrucous carcinoma of the oral cavity: expression of bcl-2, p53, and Her-2/neu, and indexes of cell turnover. Cancer Detect Prev, 21, 483-9.
  9. Epivatianos A (1995). Argyrophilic nucleolar organizer region associated proteins in human oral normal mucosa, verrucous carcinoma, and squamous cell carcinoma. Ann Dent, 54, 25-9.
  10. Gerdes J, Lelle RJ, Pickartz H,et al (1986). Growth fractions in breast cancers determined in situ with monoclonal antibody Ki-67. J Clin Pathol, 39, 977-80. https://doi.org/10.1136/jcp.39.9.977
  11. Gonzalez-Moles MA, Ruiz-Avila I, Rodriguez-Archilla A, Martinez-Lara I (2000). Suprabasal expression of Ki-67 antigen as a marker for the presence and severity of oral epithelial dysplasia. Head Neck, 22, 658-61. https://doi.org/10.1002/1097-0347(200010)22:7<658::AID-HED3>3.0.CO;2-A
  12. Junghanel A, Berndt A, Kosmehl H, Hyckel P (1998). Cell kinetics of oral squamousepithelial carcinomas. Determination of the proliferation index and apoptosis rate with the TUNEL method. Mund Kiefer Gesichtschir, 2, 250-5. https://doi.org/10.1007/s100060050069
  13. German. Kannan S, Chandran GJ, Pillai KR,et al (1996). Expression of p53 in leukoplakia and squamous cell carcinoma of the oral mucosa: correlation with expression of Ki67. Clin Mol Pathol, 49, 170-5. https://doi.org/10.1136/jcp.49.2.170
  14. Klieb HB, Raphael SJ (2007). Comparative study of the expression of p53, Ki67, E-cadherin and MMP-1 in verrucous hyperplasia and verrucous carcinoma of the oral cavity. Head Neck Pathol, 1, 118-22. https://doi.org/10.1007/s12105-007-0029-y
  15. Kurokawa H, Zhang M, Matsumoto S, et al (2005). The relationship of the histologic grade at the deep invasive front and the expression of Ki-67 antigen and p53 protein in oral squamous cell carcinoma. J Oral Pathol Med, 34, 602-7. https://doi.org/10.1111/j.1600-0714.2005.00358.x
  16. Lessard JL, Robinson RA, Hoffman HT (2001). Differential expression of ras signal transduction mediators in verrucous and squamous cell carcinomas of the upper aerodigestive tract. Arch Pathol Lab Med, 125, 1200-3.
  17. Liu SC, Klein-Szanto AJ (2000). Markers of proliferation in normal and leukoplakic oral epithelia. Oral Oncol, 36, 145-51. Review. https://doi.org/10.1016/S1368-8375(99)00076-7
  18. Mate JL, Ariza A, Aracil C, et al (1996). Cyclin D1 overexpression in non-small cell lung carcinoma: correlation with Ki67 labelling index and poor cytoplasmic differentiation. J Pathol, 180, 395-9. https://doi.org/10.1002/(SICI)1096-9896(199612)180:4<395::AID-PATH688>3.0.CO;2-C
  19. McCoy JM, Waldron CA (1981). Verrucous carcinoma of the oral cavity. A review of forty-nine cases. Oral Surg Oral Med Oral Pathol, 52, 623-9. https://doi.org/10.1016/0030-4220(81)90081-5
  20. Mulder AH, Van Hootegem JC, Sylvester R, et al (1992). Prognostic factors in bladder carcinoma: histologic parameters and expression of a cell cycle-related nuclear antigen (Ki-67). J Pathol, 166, 37-43. https://doi.org/10.1002/path.1711660107
  21. Nemes JA, Nemes Z, Marton IJ (2005). p21WAF1/CIP1 expression is a marker of poor prognosis in oral squamous cell carcinoma. J Oral Pathol Med, 34, 274-9. https://doi.org/10.1111/j.1600-0714.2005.00310.x
  22. Ono Y, Nakanishi Y, Gotoh M, Sakamoto M, Hirohashi S (2002). Epidermal growth factor receptor gene amplification is correlated with laminin-5 gamma2 chain expression in oral squamous cell carcinoma cell lines. Cancer Lett, 175, 197-204. https://doi.org/10.1016/S0304-3835(01)00682-6
  23. Pereira MC, Oliveira DT, Landman G, Kowalski LP (2007). Histologic subtypes of oral squamous cell carcinoma: prognostic relevance. J Can Dent Assoc ,73, 339-44.
  24. Ramires M, David L, Leitao D, et al (1997). Ki67 labelling index in gastric carcinomas. An immunohistochemical study using double staining for the evaluation of the proliferative activity of diffuse-type carcinomas. J Pathol ,182, 62-7. https://doi.org/10.1002/(SICI)1096-9896(199705)182:1<62::AID-PATH849>3.0.CO;2-2
  25. Saito T, Nakajima T, Mogi K (1999). Immunohistochemical analysis of cell cycle-associated proteins p16, pRb, p53, p27 and Ki-67 in oral cancer and precancer with special reference to verrucous carcinomas. J Oral Pathol Med, 28, 226-32.
  26. Salesiotis A, Soong R, Diasio RB, Frost A, Cullen KJ (2003). Capecitabine induces rapid, sustained response in two patients with extensive oral verrucous carcinoma. Clin Cancer Res, 9, 580-5.
  27. Santos-Garcia A, Abad-Hernandez MM, Fonseca-Sanchez E, Cruz-Hernandez JJ, Bullon-Sopelana A (2005). Proteic expression of p53 and cellular proliferation in oral leukoplakias. Med Oral Patol Oral Cir Bucal, 10, 5-8; 1-5. English, Spanish.
  28. Stankiewicz E, Kudahetti SC, Prowse DM, et al (2009). HPV infection and immunochemical detection of cell-cycle markers in verrucous carcinoma of the penis. Mod Pathol , 22, 1160-8. https://doi.org/10.1038/modpathol.2009.77
  29. Suomela S, Elomaa O, Skoog T, et al (2009). CCHCR1 is up-regulated in skin cancer and associated with EGFR expression. PLoS One, 4, e6030. https://doi.org/10.1371/journal.pone.0006030
  30. Theegarten D, Barfuss A, Gellrich NC, Philippou S (1997). Expression of proliferation markers PCNA and MIB 1 in verrucous squamous epithelial carcinoma of the oral cavity. Mund Kiefer Gesichtschir, 1, 133-6. German. https://doi.org/10.1007/BF03043532
  31. Tumuluri V, Thomas GA, Fraser IS (2002). Analysis of the Ki-67 antigen at the invasive tumour front of human oral squamous cell carcinoma. J Oral Pathol Med, 31, 598-604. https://doi.org/10.1034/j.1600-0714.2002.00042.x
  32. Tumuluri V, Thomas GA, Fraser IS (2004). The relationship of proliferating cell density at the invasive tumour front with prognostic and risk factors in human oral squamous cell carcinoma. J Oral Pathol Med, 33, 204-8. https://doi.org/10.1111/j.0904-2512.2004.00178.x
  33. Wenig BM (2002). Squamous cell carcinoma of the upper aerodigestive tract: precursors and problematic variants. Mod Pathol, 15, 229-54. Review. https://doi.org/10.1038/modpathol.3880520
  34. Wu M, Putti TC, Bhuiya TA (2002). Comparative study in the expression of p53, EGFR, TGF-alpha, and cyclin D1 in verrucous carcinoma, verrucous hyperplasia, and squamous cell carcinoma of head and neck region. Appl Immunohistochem Mol Morphol, 10, 351-6. https://doi.org/10.1097/00022744-200212000-00011

Cited by

  1. Expression of Matrix Metalloproteinase-10 at Invasive Front of Squamous Cell Carcinoma and Verrucous Carcinoma in the Oral Cavity vol.16, pp.15, 2015, https://doi.org/10.7314/APJCP.2015.16.15.6609
  2. Diagnostic Biomarkers in Oral Verrucous Carcinoma: A Systematic Review vol.23, pp.1, 2017, https://doi.org/10.1007/s12253-016-0150-x
  3. A novel genomic signature reclassifies an oral cancer subtype vol.137, pp.10, 2015, https://doi.org/10.1002/ijc.29615
  4. Oral verrucous carcinoma: From multifactorial etiology to diverse treatment regimens (Review) vol.49, pp.1, 2016, https://doi.org/10.3892/ijo.2016.3501